EFTA Document EFTA01492837

FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 2/1/12 to 2/29/12 Trade Date Type Descripdon Quantity Per Unit Amount Market Cost Sett 'e Date Settled Securities Purchased 2/9 Purchase 2/14 ALLY FINANCIAL INC 812% PFD @ 22.20 1,776,000.00 BROKERAGE 4900.00 J.P. MORGAN SECURITIES LLC (ID: 02005N-30-8) 80900.000 22.25 (1,780,000.00) 2/9 2/15 Purchase BRASKEM FINANCE LTD 1W 7 3/8% OCT 29 2049 DTD 10/04/2010 HELD BY EUROCLEAR ISIN US10553YAC93 SEDOL 0.31AUX06 (ID: 10553Y-9A-5) 300,000.000 100.40 (301,125.00) 2/10 2/15 Purchase EV ENERGY PARTNER LP 0 67.95 J.P. MORGAN SECURITIES LLC (ID: 26926V-10-7) 1,800.000 67.95 (122,310.00) 2/10 2/15 Purchase IRONWOOD PHARMACEUTICALS INC 0 15.09 J.P. MORGAN SECURITIES LLC (ID: 46333X-10-8) 1,900.000 15.09 (28,671.00) 2/14 2/17 Purchase ARIAD PHARMACEUTICALS INC 0 15.15868 250,648.77 BROKERAGE 826.75 J.P. MORGAN SECURITIES LLC (ID: 04033A-10-0) 16,535.000 15.209 (251,475.52) 2/14 2/17 Purchase BIGGER IDEC INC @ 119.4989 250,350.20 BROKERAGE 104.75 J.P. MORGAN SECURITIES LLC (ID: 09062X-10-3) 2,095.000 119.549 (250,45495) 2714 2/17 Purchase HSBC MARKET PLUS SPX 06/17/13 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 0100.00 JP MORGAN SECURITIES LLC (BIDL) (ID: 4042K1-X0-1) 5,000,000.000 100.00 (5,000,000.00) 2/15 2/21 Purchase ALNYLAM PHARMACEUTICALS INC 010.75 J.P. MORGAN SECURITIES LLC (ID: 020430-10-7) 4,050.000 10.75 (43,537.50) 2/15 2/21 Purchase RAYMOND JAMES FINANCIAL INC 0 34.00 J.P. MORGAN SECURITIES LLC (ID: 754730-10-9) 3,150.000 34.00 (107,100.00) 2/22 2/24 Purchase TWO HORS INVT CORP COM O 9.90 J.P. MORGAN SECURITIES LLC (ID: 90187B-10-1) 9,000.000 9.90 (89,100.00) JP Morgan Account W23560001 Page 25 of 33 Consolidated Statement Page 28 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00015654 SDNY_GM_00284852 EFTA01492837